The devastating effect of severe bacterial infections of the eye and the development of resistant organisms to the antibiotics used demand that a constant appraisal be made of the ocular pharmacodynamics and pharmacokinetics of new antibacterial agents. There is often difficulty in isolating causative organisms in ophthalmology, and thus the search continues for broader spectrum and safer antibiotics.
Cephaloridine and cephalothin are effective broad spectrum injectable antibiotics. The penetration of cephaloridine (Riley et al., 1968; Records, 1968 Records, , 1969a Records, , 1969b Richards et al., 1972) and of cephalothin (Mizukawa et al., 1965; Hatano et al., 1966) into human aqueous has been studied after parenteral administration. It has been shown that adequate therapeutic levels of both these cephalosporins are achieved in the primary aqueous after injection, but cephaloridine shows superior ocular penetration and in addition gives less pain at the site of intramuscular injection.
The major defect of these first-generation cephalosporins is that they are hydrolysed by the 3-lactamases of many Gram-negative bacteria.
However, the newer cephalosporins such as cefamandole, cefoxitin, and cefuroxime (O 'Callaghan, 1975) have a much broader spectrum of activity (Table 1) , the 2 latter mainly because of a substantially increased resistance to many bacterial Plactamases produced by a number of Gram-negative organisms. Axelrod and Kochman (1976) have studied the intraocular penetration of cefamandole in 7 patients who were undergoing elective cataract extraction. They showed that after an intravenous or intramuscular injection of 1 g, aqueous levels of up to 1-1 ,ug/ml were seen between 1-1 and 2-5 hours after injection, though in 2 of the patients no cefamandole was detected in the aqueous 4 hours after parenteral administration.
The purpose of this study was to determine the aqueous levels of cefuroxime after an intramuscular or intravenous dose in patients undergoing routine cataract extraction. 687
Sixty patients (27 male, 33 female; age range, 36 to 93 years) who were about to undergo cataract extraction were selected for study. After being informed of the nature of the study patients gave their informed consent to an additional procedure being carried out. Half the patients had their operation at the Oxford Eye Hospital and the others at the Royal Berkshire Hospital. A similar protocol was followed in each centre, the only difference being that in Oxford patients received cefuroxime (1 or 1 5 g) intravenously, whereas in Reading cefuroxime (1 g) was given intramuscularly.
All patients with a history of allergy were excluded from the study, and no patient received topical prophylactic antibiotics. Cefuroxime was administered between 0 5 and 6 hours before the time of aqueous tap.
After the patient had been anaesthetised and the eye prepared, before the opening of the anterior chamber, the globe was grasped over the medial rectus and the chamber entered with a fine aspiration needle (No. 27) on a Mantoux syringe through the presection groove. With the bevel down a sample of aqueous was removed (100 to 200 ,ul). The chamber was reformed with Ringer's saline, though the paracentesis wound and cataract surgery proceeded in routine fashion.
The aqueous sample was placed in a microcentrifuge tube, capped and labelled with a study number, and stored at -40°C. A simultaneous venous blood sample was taken, the plasma being removed for storage at -40'C until analysis.
Cefuroxime was assayed in the plasma and aqueous by the agar diffusion method using Bacillus subtilis 1904E as the assay organism.
Results
The details of the patients studied and plasma and aqueous levels of cefuroxime obtained are given in Table 2 . Thirty patients received I g of cefuroxime by intramuscular injection, and the resulting aqueous levels measured between 0 5 and 6 hours after injection ranged from < 0-3 to 2-2 jig/ml (Fig. 1), with a median value of 0 9 ,ug/ml. Eleven patients received 1 g of cefuroxime and 19 patients 1 5 g of cefuroxime intravenously. The median aqueous level measured between 25 minutes and 5 hours after administration by this route was 1 6 ,ug/ml (range, 0-5 to 3-1 ,ug/ml) for the 1 5 g dose and 1-7 ,ug/ml (range, <0 3 to 5 7 ,ug/ml) for the 1 g dose (Fig. 1) . Thus, the cefuroxime levels in the aqueous humour were higher after intravenous than after intramuscular administration (Figs. 1 and 2) , with the levels (Sparling, 1971 
